Nilo Saúde’s $10 Million Series A Funding Round

Bronstein, Zilberberg, Chueiri e Potenza Advogados advised Nilo Saúde on the deal.
Nelson Mullins Riley & Scarborough LLP provided legal counsel for SoftBank Latin America Fund.

Nilo Saúde has received USD10 million (BRL54,06 million) capital injection in a Series A funding round from Global Founders Capital, SoftBank Latin America Fund, TAU Ventures, Two Culture Capital, The Fund, Maya Capital, Canary, Grão Venture Capital and Inflection Capital.

Founded in 2020 and based in São Paulo, Nilo Saúde is a healthtech specialized in offering a software for relationship management and patient care.

SoftBank Latin America Fund is a venture fund affiliated with Japan’s SoftBank Group Corp. dedicated to investing exclusively in the technology sector in the fast-growing Latin American market.

Bronstein, Zilberberg, Chueiri e Potenza Advogados advised Nilo with a team led by partner Guilherme Potenza (Picture), supported by associate Bruna Fernandes.

The Nelson Mullins’ team included partner Leandro Molina and associate Mario Bolaños. 

Involved fees earner: Bruna Fernandes – Bronstein, Zilberberg, Chueiri & Potenza Advogados; Guilherme Potenza – Bronstein, Zilberberg, Chueiri & Potenza Advogados; Mario Bolaños – Nelson Mullins Riley & Scarborough LLP; Leandro Molina – Nelson Mullins Riley & Scarborough LLP;

Law Firms: Bronstein, Zilberberg, Chueiri & Potenza Advogados; Nelson Mullins Riley & Scarborough LLP;

Clients: Nilo Saúde; SoftBank Latin America Fund;